IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

NCT00567489 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

ESRD
Diabetes
CAPD
APD

Interventions

DRUG: Physioneal
DRUG: Dianeal
DRUG: Extraneal
DRUG: Nutrineal

Sponsor

Vantive Health LLC

Collaborators

[object Object]